Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A preclinical and clinical rationale for quetiapine in mood syndromes.
McIntyre RS, Soczynska JK, Woldeyohannes HO, Alsuwaidan M, Konarski JZ. McIntyre RS, et al. Among authors: woldeyohannes ho. Expert Opin Pharmacother. 2007 Jun;8(9):1211-9. doi: 10.1517/14656566.8.9.1211. Expert Opin Pharmacother. 2007. PMID: 17563257 Review.
Aripiprazole: pharmacology and evidence in bipolar disorder.
McIntyre RS, Soczynska JK, Woldeyohannes HO, Miranda A, Konarski JZ. McIntyre RS, et al. Among authors: woldeyohannes ho. Expert Opin Pharmacother. 2007 May;8(7):1001-9. doi: 10.1517/14656566.8.7.1001. Expert Opin Pharmacother. 2007. PMID: 17472545 Review.
Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?
McIntyre RS, Soczynska JK, Woldeyohannes HO, Lewis GF, Leiter LA, MacQueen GM, Miranda A, Fulgosi D, Konarski JZ, Kennedy SH. McIntyre RS, et al. Among authors: woldeyohannes ho. Expert Opin Pharmacother. 2007 Aug;8(11):1615-28. doi: 10.1517/14656566.8.11.1615. Expert Opin Pharmacother. 2007. PMID: 17685880 Review.
Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials.
McIntyre RS, Muzina DJ, Adams A, Lourenco MT, Law CW, Soczynska JK, Woldeyohannes HO, Nathanson J, Kennedy SH. McIntyre RS, et al. Among authors: woldeyohannes ho. Expert Opin Pharmacother. 2009 Dec;10(18):3061-75. doi: 10.1517/14656560903448837. Expert Opin Pharmacother. 2009. PMID: 19954275 Review.
Medical comorbidity in bipolar disorder: re-prioritizing unmet needs.
McIntyre RS, Soczynska JK, Beyer JL, Woldeyohannes HO, Law CW, Miranda A, Konarski JZ, Kennedy SH. McIntyre RS, et al. Among authors: woldeyohannes ho. Curr Opin Psychiatry. 2007 Jul;20(4):406-16. doi: 10.1097/YCO.0b013e3281938102. Curr Opin Psychiatry. 2007. PMID: 17551358 Review.
Maintenance treatment in bipolar disorder: a focus on aripiprazole.
McIntyre RS, Woldeyohannes HO, Yasgur BS, Soczynska JK, Miranda A, Konarski JZ. McIntyre RS, et al. Among authors: woldeyohannes ho. Expert Rev Neurother. 2007 Aug;7(8):919-25. doi: 10.1586/14737175.7.8.919. Expert Rev Neurother. 2007. PMID: 17678485 Review.
Should Depressive Syndromes Be Reclassified as "Metabolic Syndrome Type II"?
McIntyre RS, Soczynska JK, Konarski JZ, Woldeyohannes HO, Law CW, Miranda A, Fulgosi D, Kennedy SH. McIntyre RS, et al. Among authors: woldeyohannes ho. Ann Clin Psychiatry. 2007 Oct-Dec;19(4):257-64. doi: 10.1080/10401230701653377. Ann Clin Psychiatry. 2007. PMID: 18058283 Review.
48 results